Pneumologia

Diretrizes internacionais de prática clínica para desmame de ventilação mecânica pediátrica.

22 Ago, 2022 | 15:00h

Executive Summary: International Clinical Practice Guidelines for Pediatric Ventilator Liberation, A PALISI Network Document – American Journal of Respiratory and Critical Care Medicine

Estudo sugere que os sintomas da Covid longa afetem 1 em cada 8 pacientes.

22 Ago, 2022 | 14:59h

Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study – The Lancet

Comunicado de imprensa: Most reliable estimates to date suggest one in eight COVID-19 patients develop long COVID symptoms – Lancet

Comentários:

Long COVID symptoms affect 1 in 8 adults, some for 2 years – CIDRAP

Covid-19: One in eight adults develops long covid symptoms, study suggests – The BMJ

Reino Unido aprova uso da vacina atualizada da Moderna para a variante Ômicron.

22 Ago, 2022 | 14:55h

UK approves updated Moderna vaccine targeting Omicron variant – Associated Press/MedicalXpress

Ver também: Covid: UK first country to approve dual-strain vaccine – BBC

Revisão | Insuficiência respiratória hipercápnica crônica e ventilação não invasiva em pessoas com doença pulmonar obstrutiva crônica.

22 Ago, 2022 | 14:41h

Chronic hypercapnic respiratory failure and non-invasive ventilation in people with chronic obstructive pulmonary disease – BMJ Medicine

Comentário no Twitter

🆕 The latest review on non-invasive ventilation aims to provide background for internists to consider this therapeutic option for their #COPD patients. Read it now ▶️ https://t.co/7mnYMPHKEp #MedTwitter #BMJMedicine #CCFCOPD @CCF_PCCM pic.twitter.com/DfmOZxAIjG

— BMJMedicine (@BMJMedicine) August 5, 2022

M-A | Eficácia e segurança da anticoagulação com heparina em dose plena em pacientes de COVID-19 internados e não críticos.

16 Ago, 2022 | 13:04h

Efficacy and safety of heparin full-dose anticoagulation in hospitalized non-critically ill COVID-19 patients: a meta-analysis of multicenter randomized controlled trials – Journal of Thrombosis and Thrombolysis

Conteúdos relacionados:

Efficacy and safety of intensified versus standard prophylactic anticoagulation therapy in patients with Covid-19: a systematic review and meta-analysis – Open Forum Infectious Diseases

Anticoagulants for people hospitalised with COVID‐19 – Cochrane Library

Anticoagulation in Patients With COVID-19: JACC Review Topic of the Week – Journal of the American College of Cardiology

Point/Counterpoint: Should therapeutic heparin be administered to acutely ill hospitalized patients with COVID-19?

Diferenças idade-sexo no impacto global de infecções de trato respiratório inferior e fatores de risco, 1990-2019: resultados do Global Burden of Disease Study 2019.

15 Ago, 2022 | 13:35h

Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019 – The Lancet Infectious Diseases

Comentário convidado: Trends in the global burden of lower respiratory infections: the knowns and the unknowns – The Lancet Infectious Diseases

Comentário no Twitter (fio – clique para saber mais)

New Research: Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019 https://t.co/rhV7lRaZvc (1/2) pic.twitter.com/I0INjaMh4I

— The Lancet Infectious Diseases (@TheLancetInfDis) August 12, 2022

M-A | Medicações para tratamento de hipertensão arterial pulmonar.

15 Ago, 2022 | 13:27h

Medications for the treatment of pulmonary arterial hypertension: a systematic review and network meta-analysis – European Respiratory Review

M-A | Acurácia diagnóstica de testes de antígeno urinário para pneumonia pneumocócica entre pacientes com pneumonia e insuficiência respiratória aguda.

15 Ago, 2022 | 13:26h

Diagnostic accuracy of urinary antigen tests for pneumococcal pneumonia among patients with acute respiratory failure suspected pneumonia: a systematic review and meta-analysis – BMJ Open

Estudo randomizado | Solução inalatória de tobramicina é efetiva em adultos com bronquiectasia e infecção por Pseudomonas aeruginosa.

12 Ago, 2022 | 18:08h

A Double-blind Randomized Placebo-controlled Phase-3 Trial of Tobramycin Inhalation Solution in Adults with Bronchiectasis with Pseudomonas aeruginosa Infection – CHEST

Comentário: Tobramycin Tames Infection in Bronchiectasis – Medscape (necessário cadastro gratuito)

Estudo relacionado: Testing the effects of combining azithromycin with inhaled tobramycin for P. aeruginosa in cystic fibrosis: a randomised, controlled clinical trial – Thorax

Remoção extracorpórea de dióxido de carbono para insuficiência respiratória aguda: revisão de potenciais indicações, prática clínica e questões para pesquisas.

12 Ago, 2022 | 17:57h

Extracorporeal carbon dioxide removal for acute respiratory failure: a review of potential indications, clinical practice and open research questions – Intensive Care Medicine